Mankind Pharma reports Q1 FY26 financial results

Mankind Pharma reports Q1 FY26 financial results. The company has announced its financial performance for the quarter ended June 30, 2026. Results include key metrics such as revenue, profit after tax, and EPS, which will influence investor sentiment. The full report is available in the NSE corporate filing.

📊 STOCKS: $MANKIND | 🏢 SECTOR: Pharma | #HIGHIMPACT #Earnings